259 related articles for article (PubMed ID: 27488851)
21. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
22. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
[TBL] [Abstract][Full Text] [Related]
24. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
25. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.
Chou CT; Chou JM; Chang TA; Huang SF; Chen CB; Chen YL; Chen RC
World J Gastroenterol; 2013 Nov; 19(42):7433-9. PubMed ID: 24259975
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
[TBL] [Abstract][Full Text] [Related]
28. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI.
Chou CT; Chen RC; Chen WT; Lii JM
J Chin Med Assoc; 2011 Feb; 74(2):62-8. PubMed ID: 21354082
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pulsed and oscillating gradient diffusion-weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model.
Wagner M; Doblas S; Poté N; Lambert SA; Ronot M; Garteiser P; Paradis V; Vilgrain V; Van Beers BE
J Magn Reson Imaging; 2020 Apr; 51(4):1065-1074. PubMed ID: 31507025
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
31. In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
Bolcaen J; Descamps B; Acou M; Deblaere K; den Broecke CV; Boterberg T; Vanhove C; Goethals I
Mol Imaging Biol; 2017 Dec; 19(6):857-866. PubMed ID: 28303489
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation.
Lin CC; Cheng YF; Chiang HJ; Lazo M; Chang CD; Tsang LL; Yu CY; Hsu HW; Chen WT; Wang CC; Liang JL; Eng HL; Chen CL; Ou HY
Transplant Proc; 2016 May; 48(4):1041-4. PubMed ID: 27320551
[TBL] [Abstract][Full Text] [Related]
33. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
[TBL] [Abstract][Full Text] [Related]
35. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
[TBL] [Abstract][Full Text] [Related]
36. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
39. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
[TBL] [Abstract][Full Text] [Related]
40. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
